Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Nichol

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Annals of Surgical Oncology|April 5, 2021
Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone TherapyElaine McKevitt, Rona Cheifetz, Kimberly DeVries, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
The impact of hypofractionated whole breast radiotherapy on local relapse in patients with Grade 3 early breast cancer: a population-based cohort studyChristopher Herbert, Alan Nichol, Ivo Olivotto, et al.
Clinical Breast Cancer|December 27, 2022
The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer InstitutionHelena Bentley, James Roberts, Malcolm Hayes, et al.
Cureus|September 21, 2017
Severe Late Toxicity After Adjuvant Breast Radiotherapy in a Patient with a Germline Ataxia Telangiectasia Mutated Gene: Future Treatment DecisionsMaryam Dosani, Kasmintan A Schrader, Alan Nichol, et al.
Annals of Surgical Oncology|June 26, 2023
Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer PatientsElizaveta Vasilyeva, Jeremy Hamm, Alan Nichol, et al.
Journal of Applied Clinical Medical Physics|July 7, 2012
Coplanar versus noncoplanar intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) treatment planning for fronto-temporal high-grade gliomaValerie Panet-Raymond, Will Ansbacher, Sergei Zavgorodni, et al.
Frontiers in Oncology|December 12, 2024
Dosimetric scorecards express precise clinical intent: alternate hippocampal-sparing whole-brain RapidPlan models favoring target coverage and homogeneity at 30 and 20 GyKareem Rayn, Anthony Magliari, Ryan Clark, et al.
Journal of Medical Screening|November 22, 2017
Signed family physician reminder letters to women overdue for screening mammography: A randomized clinical trialElisa K Chan, Christine Wilson, Scott Tyldesley, et al.
Cancer|December 2, 2021
Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancerMegan E Tesch, Caroline Speers, Rekha M Diocee, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2022
pN0(i+) and pN1mi Breast Cancer: Treatment and Outcomes in Comparison With pN0 and pN1a in the Modern EraMaryam Dosani, Sarah Nicole Hamilton, Lovedeep Gondara, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|April 5, 2021
Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone TherapyElaine McKevitt, Rona Cheifetz, Kimberly DeVries, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
The impact of hypofractionated whole breast radiotherapy on local relapse in patients with Grade 3 early breast cancer: a population-based cohort studyChristopher Herbert, Alan Nichol, Ivo Olivotto, et al.
Clinical Breast Cancer|December 27, 2022
The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer InstitutionHelena Bentley, James Roberts, Malcolm Hayes, et al.
Cureus|September 21, 2017
Severe Late Toxicity After Adjuvant Breast Radiotherapy in a Patient with a Germline Ataxia Telangiectasia Mutated Gene: Future Treatment DecisionsMaryam Dosani, Kasmintan A Schrader, Alan Nichol, et al.
Annals of Surgical Oncology|June 26, 2023
Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer PatientsElizaveta Vasilyeva, Jeremy Hamm, Alan Nichol, et al.
Journal of Applied Clinical Medical Physics|July 7, 2012
Coplanar versus noncoplanar intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) treatment planning for fronto-temporal high-grade gliomaValerie Panet-Raymond, Will Ansbacher, Sergei Zavgorodni, et al.
Frontiers in Oncology|December 12, 2024
Dosimetric scorecards express precise clinical intent: alternate hippocampal-sparing whole-brain RapidPlan models favoring target coverage and homogeneity at 30 and 20 GyKareem Rayn, Anthony Magliari, Ryan Clark, et al.
Journal of Medical Screening|November 22, 2017
Signed family physician reminder letters to women overdue for screening mammography: A randomized clinical trialElisa K Chan, Christine Wilson, Scott Tyldesley, et al.
Cancer|December 2, 2021
Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancerMegan E Tesch, Caroline Speers, Rekha M Diocee, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2022
pN0(i+) and pN1mi Breast Cancer: Treatment and Outcomes in Comparison With pN0 and pN1a in the Modern EraMaryam Dosani, Sarah Nicole Hamilton, Lovedeep Gondara, et al.
Pageof 8